| Literature DB >> 27500498 |
Lisa Asano1, Tsuyoshi Waku2, Rumi Abe3, Naoyuki Kuwabara4, Ichiaki Ito5, Junn Yanagisawa5, Kazuo Nagasawa3, Toshiyuki Shimizu6.
Abstract
The active metabolite of vitamin D3 , 1α,25-dihydroxyvitamin D3 , acts as a ligand for the vitamin D receptor (VDR) and activates VDR-mediated gene expression. Recently, we characterized 1α,25-dihydroxyvitamin D3 -26,23-lactams (DLAMs), which mimic vitamin D3 metabolites, as noncalcemic VDR ligands that barely activate the receptor. In this study, we present structural insights onto the regulation of VDR function by DLAMs. X-ray crystallographic analysis revealed that DLAMs induced a large conformational change in the loop region between helices H6 and H7 in the VDR ligand-binding domain. Our structural analysis suggests that targeting of the loop region may be a new mode of VDR regulation.Entities:
Keywords: crystal structure; vitamin D lactam derivative; vitamin D receptor
Mesh:
Substances:
Year: 2016 PMID: 27500498 DOI: 10.1002/1873-3468.12348
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124